RARS1

Arginine--tRNA ligase, cytoplasmic · P54136 · RARS1 on Sugi Atlas →

68 patent compounds predicted against RARS1, 52 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Adenosine Phosphate Adenosine Phosphate (SCHEMBL15670688) 0.53 2/20
SCHEMBL30817311 SCHEMBL30817311 1.00 1/20
SCHEMBL4253015 SCHEMBL4253015 0.81 1/20
SCHEMBL13773212 SCHEMBL13773212 0.81 1/20
SCHEMBL13773213 SCHEMBL13773213 0.81 1/20
SCHEMBL13773214 SCHEMBL13773214 0.81 1/20
SCHEMBL29390953 SCHEMBL29390953 0.81 1/20
SCHEMBL5063184 SCHEMBL5063184 0.80 1/20
SCHEMBL5063189 SCHEMBL5063189 0.80 1/20
SCHEMBL3187637 SCHEMBL3187637 0.79 1/20
SCHEMBL3187665 SCHEMBL3187665 0.79 1/20
SCHEMBL21068060 SCHEMBL21068060 0.79 1/20
SCHEMBL13773209 SCHEMBL13773209 0.78 1/20
SCHEMBL13773210 SCHEMBL13773210 0.78 1/20
SCHEMBL13773211 SCHEMBL13773211 0.78 1/20
SCHEMBL5067246 SCHEMBL5067246 0.78 1/20
SCHEMBL3500697 SCHEMBL3500697 0.77 1/20
SCHEMBL178823 SCHEMBL178823 0.77 1/20
SCHEMBL178824 SCHEMBL178824 0.77 1/20
SCHEMBL4313369 SCHEMBL4313369 0.76 1/20

Clinical trials — most relevant to RARS1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19 PHASE2UNKNOWN
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome PHASE2NOT_YET_RECRUITING
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid PHASE1UNKNOWN
Gene Therapy for the Treatment of Fanconi's Anemia Type C PHASE1COMPLETED
Mechanisms of Inherited Retinal Dystrophies Using Whole Genome Sequencing and in Vitro and in Vivo Models nanCOMPLETED
Natural History Study of Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL) nanRECRUITING
Quantifying Disease Progression in LBSL nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
Genetic Analysis of Fraser Syndrome and Fryns Syndrome nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
Effect of Short-Term Exercise Training on ATP Synthesis in Relatives of Type 2 Diabetic Humans nanCOMPLETED
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Calf Muscle Strength in Mitochondrial Diseases nanCOMPLETED
The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study nanNOT_YET_RECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Mitochondrial Disease-associated ImmunoDeficiencies nanRECRUITING
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) nanRECRUITING
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Multi-Dimensional Genomic Dissection of Ring Chromosome 14 Syndrome nanACTIVE_NOT_RECRUITING
Nicotinamide Riboside and Mitochondrial Biogenesis nanCOMPLETED
Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells nanRECRUITING
McArdle Disease Treatment by Ketogenic Diet nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Replacement of Vitamin D in Patients With Active Tuberculosis nanCOMPLETED
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a RARS1 binder may also engage these)

ProteinNameSimilarity
Q5RA20 1.000 Q5RA20 →
Q5ZM11 1.000 Q5ZM11 →
A7YW98 1.000 A7YW98 →
P37880 1.000 P37880 →
Q9D0I9 1.000 Q9D0I9 →
P40329 1.000 P40329 →
Q6P1S4 1.000 Q6P1S4 →
Q9C713 1.000 Q9C713 →
C4K487 0.999 C4K487 →
O23247 0.999 O23247 →
Q9VXN4 0.999 Q9VXN4 →
Q7VP38 0.998 Q7VP38 →
P43832 0.997 P43832 →
Q6MLI2 0.997 Q6MLI2 →
Q73H00 0.997 Q73H00 →
Q2SMY0 0.997 Q2SMY0 →
B0UUF1 0.997 B0UUF1 →
Q8SRD8 0.997 Q8SRD8 →
O84304 0.996 O84304 →
A6VNB3 0.996 A6VNB3 →
A5UJ40 0.996 A5UJ40 →
B3CNK5 0.996 B3CNK5 →
Q4QL12 0.996 Q4QL12 →
Q66AV1 0.996 Q66AV1 →
Q5L5J6 0.996 Q5L5J6 →
Q8ZEV7 0.995 Q8ZEV7 →
B0BBT3 0.995 B0BBT3 →
C6DFD9 0.995 C6DFD9 →
A6UD99 0.995 A6UD99 →
A8FQM2 0.995 A8FQM2 →